Deal Announcement
goetzpartners advised Mipharm S.p.A
Due Diligence
Healthcare and Life Sciences
Transaction


July 2024

goetzpartners advised
Mipharm S.p.a., a portfolio company of Alto Partners SGR, with a
Commercial Due Diligence
on the merger with Doppel Farmaceutici S.r.l., a portfolio company of Trilantic Europe
Value not disclosed
Scroll down
Contact

Giovanni Calia
Due Diligence, Value Creation and Exit Readiness, Portfolio Strategy and Buy & Build, Principal Investors and Private Equity